The impact of EU chemicals policy and legislation on green transformations in the pharmaceutical sector in the EU

Funded by the Research Council of Finland, the four-year PharGTrans project examines how changes in EU chemicals policy and legislation may affect green transformations in the pharmaceutical sector in the European Union. The project is led by Senior Researcher, Docent Mirella Miettinen at the University of Eastern Finland Law School, with partners from the Universities of Eastern Finland, Helsinki, Stockholm and Aarhus representing law, pharmacy and environmental sciences.
The project examines the cross-cutting effects of measures supporting green transformations in EU chemicals policy and legislation on the practices of pharmaceutical actors, as well as their perceptions of the depth of green transformations needed. Empirical studies on how different actors are implementing green transformations in practice are scarce. The project will conduct an interview study among various stakeholders in the pharmaceutical sector: researchers, industry, interest groups, public authorities and political decision-makers.